• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于偏好的衡量标准的评估:能否使用现有的偏好数据来选择更小的健康状态样本?

Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?

机构信息

Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, P.O.BOX: 11-0236, Riad El Solh, Beirut, 1107-2020, Lebanon.

Health Economics and Decision Science, School of Health and Related Research, The University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.

出版信息

Eur J Health Econ. 2019 Mar;20(2):245-255. doi: 10.1007/s10198-018-0991-1. Epub 2018 Jul 6.

DOI:10.1007/s10198-018-0991-1
PMID:29980950
Abstract

BACKGROUND

Different countries have different preferences regarding health, and there are different value sets for popular preference-based measures across different countries. However, the cost of collecting data to generate country-specific value sets can be prohibitive for countries with smaller population size or low- and middle-income countries (LMIC). This paper explores whether existing preference weights could be modelled alongside a small own country valuation study to generate representative estimates. This is explored using a case study modelling UK data alongside smaller US samples to generate US estimates.

METHODS

We analyse EQ-5D valuation data derived from representative samples of the US and UK populations using time trade-off to value 42 health states. A nonparametric Bayesian model was applied to estimate a US value set using the full UK dataset and subsets of the US dataset for 10, 15, 20 and 25 health states. Estimates are compared to a US value set estimated using US values alone using mean predictions and root mean square error.

RESULTS

The results suggest that using US data elicited for 20 health states alongside the existing UK data produces similar predicted mean valuations and RMSE as the US value set, while 25 health states produce the exact features.

CONCLUSIONS

The promising results suggest that existing preference data could be combined with a small valuation study in a new country to generate preference weights, making own country value sets more achievable for LMIC. Further research is encouraged.

摘要

背景

不同国家对健康有不同的偏好,不同国家的偏好指标也有不同的价值体系。然而,对于人口规模较小或中低收入国家(LMIC)来说,收集数据以生成特定国家的价值体系的成本可能过高。本文探讨了是否可以将现有的偏好权重与小规模的本国估值研究结合起来,以生成代表性的估计值。这是通过使用来自英国和美国小样本的案例研究模型来生成美国估计值来探索的。

方法

我们使用时间权衡法分析了来自美国和英国代表性样本的 EQ-5D 估值数据,以评估 42 种健康状态的价值。应用非参数贝叶斯模型,使用完整的英国数据集和美国数据集的子集(10、15、20 和 25 个健康状态)来估计美国的价值体系。将估计值与仅使用美国价值的美国价值体系进行比较,使用均值预测和均方根误差进行比较。

结果

结果表明,使用美国的 20 个健康状态数据和现有的英国数据相结合,可以产生与美国价值体系相似的预测均值估值和 RMSE,而 25 个健康状态则产生完全相同的特征。

结论

有希望的结果表明,现有的偏好数据可以与新国家的小规模估值研究相结合,以生成偏好权重,使 LMIC 更有可能生成本国的价值体系。鼓励进一步研究。

相似文献

1
Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?基于偏好的衡量标准的评估:能否使用现有的偏好数据来选择更小的健康状态样本?
Eur J Health Econ. 2019 Mar;20(2):245-255. doi: 10.1007/s10198-018-0991-1. Epub 2018 Jul 6.
2
Valuation of preference-based measures: can existing preference data be used to generate better estimates?基于偏好的衡量指标的评估:现有的偏好数据是否可以用来生成更好的估计值?
Health Qual Life Outcomes. 2018 Jun 5;16(1):116. doi: 10.1186/s12955-018-0945-4.
3
Bayesian modeling of health state preferences: could borrowing strength from existing countries' valuations produce better estimates.健康状态偏好的贝叶斯建模:从现有国家的评估中借鉴优势能否产生更好的估计。
Eur J Health Econ. 2021 Jul;22(5):773-788. doi: 10.1007/s10198-021-01289-x. Epub 2021 Mar 24.
4
A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.采用非参数贝叶斯方法对美国和英国 EQ-5D 健康状态估值进行比较。
Stat Med. 2010 Jul 10;29(15):1622-34. doi: 10.1002/sim.3874.
5
Bayesian nonparametric estimation of EQ-5D utilities for United States using the existing United Kingdom data.利用英国现有数据对美国EQ-5D效用进行贝叶斯非参数估计。
Health Qual Life Outcomes. 2017 Oct 6;15(1):195. doi: 10.1186/s12955-017-0770-1.
6
Modeling SF-6D Health Utilities: Is Bayesian Approach Appropriate?SF-6D 健康效用值建模:贝叶斯方法是否适用?
Int J Environ Res Public Health. 2021 Aug 9;18(16):8409. doi: 10.3390/ijerph18168409.
7
Use of a Non-parametric Bayesian Method to Model Health State Preferences: An Application to Polish and Irish EQ-5D-5L Valuations.使用非参数贝叶斯方法建模健康状态偏好:波兰和爱尔兰 EQ-5D-5L 估值的应用。
Front Public Health. 2022 Jun 23;10:917728. doi: 10.3389/fpubh.2022.917728. eCollection 2022.
8
3125 steps to perfect health: a nonparametric approach to developing the EQ-5D-5L value set.迈向完美健康的 3125 步:开发 EQ-5D-5L 值集的非参数方法。
Qual Life Res. 2020 Nov;29(11):3109-3118. doi: 10.1007/s11136-020-02589-0. Epub 2020 Jul 23.
9
Valuations of EQ-5D health states: are the United States and United Kingdom different?EQ-5D健康状态的估值:美国和英国有所不同吗?
Med Care. 2005 Mar;43(3):221-8. doi: 10.1097/00005650-200503000-00004.
10
Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.比较三种欧洲国家用 EQ-5D 衡量的人口健康状况的不同评估方法。
Value Health. 2009 Jul-Aug;12(5):750-8. doi: 10.1111/j.1524-4733.2009.00509.x.

引用本文的文献

1
Modeling SF-6D Health Utilities: Is Bayesian Approach Appropriate?SF-6D 健康效用值建模:贝叶斯方法是否适用?
Int J Environ Res Public Health. 2021 Aug 9;18(16):8409. doi: 10.3390/ijerph18168409.
2
Analysis of SF-6D Health State Utility Scores: Is Beta Regression Appropriate?SF-6D健康状态效用评分分析:贝塔回归是否适用?
Healthcare (Basel). 2020 Dec 1;8(4):525. doi: 10.3390/healthcare8040525.
3
Examining the Feasibility and Acceptability of Valuing the Arabic Version of SF-6D in a Lebanese Population.评估黎巴嫩人群中 SF-6D 阿拉伯语版本的可行性和可接受性。

本文引用的文献

1
The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment.条件特异性偏好测量在卫生技术评估中的作用。
Pharmacoeconomics. 2017 Dec;35(Suppl 1):33-41. doi: 10.1007/s40273-017-0546-9.
2
International Regulations and Recommendations for Utility Data for Health Technology Assessment.国际卫生技术评估实用数据法规与建议。
Pharmacoeconomics. 2017 Dec;35(Suppl 1):11-19. doi: 10.1007/s40273-017-0544-y.
3
A Comparison of Japan and U.K. SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method.
Int J Environ Res Public Health. 2020 Feb 6;17(3):1037. doi: 10.3390/ijerph17031037.
使用非参数贝叶斯方法对日本和英国SF-6D健康状态估值的比较
Appl Health Econ Health Policy. 2015 Aug;13(4):409-20. doi: 10.1007/s40258-015-0171-8.
4
A comparison of Hong Kong and United Kingdom SF-6D health states valuations using a nonparametric Bayesian method.使用非参数贝叶斯方法对香港和英国 SF-6D 健康状态估值进行比较。
Value Health. 2014 Jun;17(4):397-405. doi: 10.1016/j.jval.2014.02.011. Epub 2014 May 10.
5
A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.采用非参数贝叶斯方法对美国和英国 EQ-5D 健康状态估值进行比较。
Stat Med. 2010 Jul 10;29(15):1622-34. doi: 10.1002/sim.3874.
6
Valuations of EQ-5D health states: are the United States and United Kingdom different?EQ-5D健康状态的估值:美国和英国有所不同吗?
Med Care. 2005 Mar;43(3):221-8. doi: 10.1097/00005650-200503000-00004.
7
US valuation of the EQ-5D health states: development and testing of the D1 valuation model.美国EQ-5D健康状态的估值:D1估值模型的开发与测试
Med Care. 2005 Mar;43(3):203-20. doi: 10.1097/00005650-200503000-00003.
8
The estimation of a preference-based measure of health from the SF-36.基于SF-36量表对健康偏好测量值的估计。
J Health Econ. 2002 Mar;21(2):271-92. doi: 10.1016/s0167-6296(01)00130-8.
9
Multiattribute and single-attribute utility functions for the health utilities index mark 3 system.健康效用指数3系统的多属性和单属性效用函数
Med Care. 2002 Feb;40(2):113-28. doi: 10.1097/00005650-200202000-00006.
10
A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments.生活质量评估量表(AQoL)与其他四种通用效用工具的比较。
Ann Med. 2001 Jul;33(5):358-70. doi: 10.3109/07853890109002090.